[CD34+ cells (beta thalassaemia) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003650
German
Original Title:
Autologe CD34+ haematopoetische Stammzellen (Beta-Thalassaemie)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/g19-19.html
Year Published:
2020
URL for published report:
https://www.iqwig.de/download/G19-19_Autologe-CD34+-haematopoetische-Stammzellen_Bewertung-35a-Absatz-1-Satz-11-SGB-V_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- beta-Thalassemia
- Antigens, CD34
- Genetic Therapy
Keywords
- Hematopoietic Stem Cells
- Beta - Thalassemia
- Health Care Costs
- Epidemiology
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.